BrightSpring Health Services (Nasdaq: BTSG) is integrating the portfolio of 107 home health and hospice assets recently acquired from UnitedHealth Group (NYSE: UNH) and Amedisys for $239 million, and company leadership sees tremendous future upside in these service areas.
The deal had been contingent on the outcome of the UnitedHealth Group’s own acquisition of Amedisys, which closed in August 2025. Some of the locations formerly belonged to LHC Group, which the insurance giant acquired in 2023.
“These assets are very complementary to our existing home health business from a geographic perspective, while also being in the same markets as our hospice locations in many cases,” BrightSpring CEO Jon Rousseau said in an earnings call. “We are thrilled to have the Amedisys and LHC Group assets and colleagues integrated into BrightSpring, as we are already taking steps to bring new and improved company capabilities to these acquired operations. This is another example of thoughtful, logical, strategic and accretive M&A that has defined our acquisitions history.”
The acquired locations generated full-year pro forma revenue of $345 million in 2025 which includes the months throughout the year prior to the transactions closing, Rousseau said.
BrightSpring is a home- and community-based health care services platform that serves more than 400,000 patients daily across all 50 states. The Louisville, Kentucky-based company provides hospice, home health, primary care, rehabilitation, pharmaceuticals and behavioral health care. Hospice represents about two-thirds of its home health segment. The segment includes the company’s home health, hospice and primary care businesses.
BrightSpring’s provider services segment earned $394 million in Q4 2025, up from $350 million year over year. For the full year 2025, the segment brought in nearly $1.5 billion, up from $1.3 billion in 2024. That’s 11% growth.
The company’s consolidated revenue for Q4 was close to $3.6 million, a nearly 30% increase from the prior year’s quarter.
BrightSpring expects continued volume growth across a number of its business lines during 2026, according to Rousseau. The company is making deeper investments in its sales teams across its segments, including home health and hospice.
The provider is also leveraging LEAN Six Sigma practices and artificial intelligence initiatives to build efficiencies and foster growth.
“We see an unbelievable runway in home health and hospice over the next five to 10 years …,” Rousseau said. “Home health for us is sort of still sitting around 10% or so of the company, and then hospice obviously has had a ton of support and has been a phenomenal performer for us. Both of those teams in our company have best-in-class management. We continue to have sales. We continue to drive technology into those businesses and are super excited about their prospects.”

